Racial variation in receipt of quality radiation therapy for prostate cancer
Daniel J. Lee(University of Pennsylvania), Karen E. Hoffman(The University of Texas MD Anderson Cancer Center), Tatsuki Koyoma(Vanderbilt University Medical Center), Li‐Ching Huang(Vanderbilt University), Zhiguo Zhao(Vanderbilt University), David F. Penson(Geriatric Research Education and Clinical Center), Matthew J. Resnick(Vanderbilt University Medical Center), Daniel A. Barocas(Vanderbilt University Medical Center)
Cited by 20
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656